GINKGO BIOWORKS HOLDINGS, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $0.00 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-05-07
- GINKGO BIOWORKS HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-31 was $92.08, a 460300.00% increase year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.02, a 100.00% increase year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $0.01, a 50.00% decline year-over-year.
- GINKGO BIOWORKS HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- GINKGO BIOWORKS HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $0.80, a 3900.00% increase from fiscal 2023.
- GINKGO BIOWORKS HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $0.02, a 0.00% change from fiscal 2022.
- GINKGO BIOWORKS HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $0.02, a 0.00% change from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $36.96 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $92.08 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | $92.08 10-Q · filed 2025-05-06 | |||
| 2024-12-31 | $0.80 10-K · filed 2025-02-25 | |||
| 2024-09-30 | $0.80 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | $0.02 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | $0.02 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | $0.02 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $0.02 10-Q · filed 2023-11-08 | |||
| 2023-06-30 | $0.01 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | $0.01 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | $0.02 10-K · filed 2023-03-13 | |||
| 2022-09-30 | $0.02 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $0.02 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | $0.02 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | $0.02 10-K · filed 2022-03-29 | |||
| 2021-09-30 | $0.01 10-Q · filed 2021-11-15 |